Photoacoustic tomography of joints aided by an Etanercept-conjugated gold nanoparticle contrast agent-an ex vivo preliminary rat study
dc.contributor.author | Chamberland, David L. | en_US |
dc.contributor.author | Agarwal, Ashish | en_US |
dc.contributor.author | Kotov, Nicholas A. | en_US |
dc.contributor.author | Fowlkes, J. Brian | en_US |
dc.contributor.author | Carson, Paul L. | en_US |
dc.contributor.author | Wang, Xueding | en_US |
dc.date.accessioned | 2009-10-08T15:32:35Z | |
dc.date.available | 2009-10-08T15:32:35Z | |
dc.date.issued | 2008 | en_US |
dc.identifier.citation | Chamberland, David L; Agarwal, Ashish; Kotov, Nicholas; Fowlkes, J Brian; Carson, Paul L; Wang, Xueding (2008). "Photoacoustic tomography of joints aided by an Etanercept-conjugated gold nanoparticle contrast agent-an ex vivo preliminary rat study." Nanotechnology 19(9):095101 (7pp). <http://hdl.handle.net/2027.42/64174> | en_US |
dc.identifier.issn | 0957-4484 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/64174 | |
dc.description.abstract | "Monitoring of anti-rheumatic drug delivery in experimental models and in human diseases would undoubtedly be very helpful for both basic research and clinical management of inflammatory diseases. In this study, we have investigated the potential of an emerging hybrid imaging technology--photoacoustic tomography--in noninvasive monitoring of anti-TNF drug delivery. After the contrast agent composed of gold nanorods conjugated with Etanercept molecules was produced, ELISA experiments were performed to prove the conjugation and to show that the conjugated anti-TNF-a drug was biologically active. PAT of ex vivo rat tail joints with the joint connective tissue enhanced by intra-articularly injected contrast agent was conducted to examine the performance of PAT in visualizing the distribution of the gold-nanorod-conjugated drug in articular tissues. By using the described system, gold nanorods with a concentration down to 1 pM in phantoms or 10 pM in biological tissues can be imaged with good signal-to-noise ratio and high spatial resolution. This study demonstrates the feasibility of conjugating TNF antagonist pharmaceutical preparations with gold nanorods, preservation of the mechanism of action of TNF antagonist along with preliminary evaluation of novel PAT technology in imaging optical contrast agents conjugated with anti-rheumatic drugs. Further in vivo studies on animals are warranted to test the specific binding between such conjugates and targeted antigen in joint tissues affected by inflammation." | en_US |
dc.format.extent | 540864 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.title | Photoacoustic tomography of joints aided by an Etanercept-conjugated gold nanoparticle contrast agent-an ex vivo preliminary rat study | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.identifier.pmid | 21817663 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/64174/1/nano8_9_095101.pdf | |
dc.identifier.doi | http://dx.doi.org/10.1088/0957-4484/19/9/095101 | en_US |
dc.identifier.source | Nanotechnology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.